{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:57:46Z","timestamp":1773154666182,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Tehran University of Medical Sciences","award":["95-04-41-33869"],"award-info":[{"award-number":["95-04-41-33869"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10067-018-4055-9","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T07:35:12Z","timestamp":1520580912000},"page":"1589-1595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ankylosing spondylitis monocyte-derived macrophages express increased level of A2A adenosine receptor and decreased level of ectonucleoside triphosphate diphosphohydrolase-1 (CD39), A1 and A2B adenosine receptors"],"prefix":"10.1007","volume":"37","author":[{"given":"Maryam","family":"Akhtari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Jalal","family":"Zargar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Vojdanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Rezaeimanesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmadreza","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"4055_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379\u20131390. https:\/\/doi.org\/10.1016\/S0140-6736(07)60635-7","journal-title":"Lancet"},{"key":"4055_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2010.79","volume":"6","author":"LS Tam","year":"2010","unstructured":"Tam LS, Gu J, Yu D (2010) Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 6:399\u2013405. https:\/\/doi.org\/10.1038\/nrrheum.2010.79","journal-title":"Nat Rev Rheumatol"},{"key":"4055_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.berh.2006.03.010","volume":"20","author":"M Rudwaleit","year":"2006","unstructured":"Rudwaleit M, Baeten D (2006) Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol 20:451\u2013471. https:\/\/doi.org\/10.1016\/j.berh.2006.03.010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4055_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/ard.62.2.127","volume":"62","author":"L Heuft-Dorenbosch","year":"2003","unstructured":"Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewe R, van ver Tempel H, Mielants H, Dougados M, van der Heijde D (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62:127\u2013132","journal-title":"Ann Rheum Dis"},{"key":"4055_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/ncprheum0157","volume":"2","author":"C Henderson","year":"2006","unstructured":"Henderson C, Davis JC (2006) Drug insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis. Nat Clin Pract Rheumatol 2:211\u2013218. https:\/\/doi.org\/10.1038\/ncprheum0157","journal-title":"Nat Clin Pract Rheumatol"},{"key":"4055_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/1759720X09359728","volume":"2","author":"LC Coates","year":"2010","unstructured":"Coates LC, Marzo-Ortega H, Bennett AN, Emery P (2010) Anti-TNF therapy in ankylosing spondylitis: insights for the clinician. Ther Adv Musculoskelet Dis 2:37\u201343. https:\/\/doi.org\/10.1177\/1759720X09359728","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"4055_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1568010054022024","volume":"4","author":"N Fujiwara","year":"2005","unstructured":"Fujiwara N, Kobayashi K (2005) Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 4:281\u2013286","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"4055_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JIR.S82320","volume":"9","author":"A Laria","year":"2016","unstructured":"Laria A, Lurati A, Marrazza M, Mazzocchi D, Re KA, Scarpellini M (2016) The macrophages in rheumatic diseases. J Inflamm Res 9:1\u201311. https:\/\/doi.org\/10.2147\/JIR.S82320","journal-title":"J Inflamm Res"},{"key":"4055_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/ar2722","volume":"11","author":"L Melis","year":"2009","unstructured":"Melis L, Elewaut D (2009) Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease? Arthritis Res Ther 11:233. https:\/\/doi.org\/10.1186\/ar2722","journal-title":"Arthritis Res Ther"},{"key":"4055_CR10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/ard.61.6.534","volume":"61","author":"D McGonagle","year":"2002","unstructured":"McGonagle D, Marzo-Ortega H, O'Connor P, Gibbon W, Hawkey P, Henshaw K, Emery P (2002) Histological assessment of the early enthesitis lesion in spondyloarthropathy. Ann Rheum Dis 61:534\u2013537","journal-title":"Ann Rheum Dis"},{"key":"4055_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1566524043479310","volume":"4","author":"D Baeten","year":"2004","unstructured":"Baeten D, De Keyser F (2004) The histopathology of spondyloarthropathy. Curr Mol Med 4:1\u201312","journal-title":"Curr Mol Med"},{"key":"4055_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/ard.59.2.135","volume":"59","author":"M Bollow","year":"2000","unstructured":"Bollow M, Fischer T, Reisshauer H, Backhaus M, Sieper J, Hamm B, Braun J (2000) Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis\u2014cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 59:135\u2013140","journal-title":"Ann Rheum Dis"},{"key":"4055_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.it.2003.11.003","volume":"25","author":"G Hasko","year":"2004","unstructured":"Hasko G, Cronstein BN (2004) Adenosine: an endogenous regulator of innate immunity. Trends Immunol 25:33\u201339","journal-title":"Trends Immunol"},{"key":"4055_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrrheum.2016.178","volume":"13","author":"BN Cronstein","year":"2017","unstructured":"Cronstein BN, Sitkovsky M (2017) Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases. Nat Rev Rheumatol 13:41\u201351. https:\/\/doi.org\/10.1038\/nrrheum.2016.178","journal-title":"Nat Rev Rheumatol"},{"key":"4055_CR15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1161\/ATVBAHA.111.226852","volume":"32","author":"G Hasko","year":"2012","unstructured":"Hasko G, Pacher P (2012) Regulation of macrophage function by adenosine. Arterioscler Thromb Vasc Biol 32:865\u2013869. https:\/\/doi.org\/10.1161\/ATVBAHA.111.226852","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4055_CR16","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/j.1476-5381.2009.00614.x","volume":"159","author":"A Buenestado","year":"2010","unstructured":"Buenestado A, Grassin Delyle S, Arnould I, Besnard F, Naline E, Blouquit-Laye S, Chapelier A, Bellamy JF, Devillier P (2010) The role of adenosine receptors in regulating production of tumour necrosis factor-alpha and chemokines by human lung macrophages. Br J Pharmacol 159:1304\u20131311. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00614.x","journal-title":"Br J Pharmacol"},{"key":"4055_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S1471-4892(02)00172-8","volume":"2","author":"G Hasko","year":"2002","unstructured":"Hasko G, Deitch EA, Szabo C, Nemeth ZH, Vizi ES (2002) Adenosine: a potential mediator of immunosuppression in multiple organ failure. Curr Opin Pharmacol 2:440\u2013444","journal-title":"Curr Opin Pharmacol"},{"key":"4055_CR18","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/sj.onc.1206184","volume":"22","author":"S Majumdar","year":"2003","unstructured":"Majumdar S, Aggarwal BB (2003) Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types. Oncogene 22:1206\u20131218. https:\/\/doi.org\/10.1038\/sj.onc.1206184","journal-title":"Oncogene"},{"key":"4055_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd2638","volume":"7","author":"G Hasko","year":"2008","unstructured":"Hasko G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7:759\u2013770. https:\/\/doi.org\/10.1038\/nrd2638","journal-title":"Nat Rev Drug Discov"},{"key":"4055_CR20","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1096\/fj.99-0508com","volume":"14","author":"G Hasko","year":"2000","unstructured":"Hasko G, Kuhel DG, Chen JF, Schwarzschild MA, Deitch EA, Mabley JG, Marton A, Szabo C (2000) Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J 14:2065\u20132074. https:\/\/doi.org\/10.1096\/fj.99-0508com","journal-title":"FASEB J"},{"key":"4055_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1124\/jpet.105.096016","volume":"317","author":"LM Kreckler","year":"2006","unstructured":"Kreckler LM, Wan TC, Ge ZD, Auchampach JA (2006) Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. J Pharmacol Exp Ther 317:172\u2013180. https:\/\/doi.org\/10.1124\/jpet.105.096016","journal-title":"J Pharmacol Exp Ther"},{"key":"4055_CR22","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1124\/jpet.107.131540","volume":"324","author":"S Ryzhov","year":"2008","unstructured":"Ryzhov S, Zaynagetdinov R, Goldstein AE, Novitskiy SV, Blackburn MR, Biaggioni I, Feoktistov I (2008) Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines. J Pharmacol Exp Ther 324:694\u2013700. https:\/\/doi.org\/10.1124\/jpet.107.131540","journal-title":"J Pharmacol Exp Ther"},{"key":"4055_CR23","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/0024-3205(93)90632-D","volume":"52","author":"V Vraux Le","year":"1993","unstructured":"Le Vraux V, Chen YL, Masson I, De Sousa M, Giroud JP, Florentin I, Chauvelot-Moachon L (1993) Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sci 52:1917\u20131924","journal-title":"Life Sci"},{"key":"4055_CR24","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.4049\/jimmunol.156.9.3435","volume":"156","author":"FG Sajjadi","year":"1996","unstructured":"Sajjadi FG, Takabayashi K, Foster AC, Domingo RC, Firestein GS (1996) Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J Immunol 156:3435\u20133442","journal-title":"J Immunol"},{"key":"4055_CR25","doi-asserted-by":"publisher","unstructured":"Blackburn MR, Vance CO, Morschl E, Wilson CN (2009) Adenosine receptors and inflammation. Handb Exp Pharmacol:215\u2013269. https:\/\/doi.org\/10.1007\/978-3-540-89615-9_8","DOI":"10.1007\/978-3-540-89615-9_8"},{"key":"4055_CR26","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/sj.cdd.4402132","volume":"14","author":"BB Fredholm","year":"2007","unstructured":"Fredholm BB (2007) Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 14:1315\u20131323. https:\/\/doi.org\/10.1038\/sj.cdd.4402132","journal-title":"Cell Death Differ"},{"key":"4055_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00085","volume":"4","author":"G Hasko","year":"2013","unstructured":"Hasko G, Cronstein B (2013) Regulation of inflammation by adenosine. Front Immunol 4:85. https:\/\/doi.org\/10.3389\/fimmu.2013.00085","journal-title":"Front Immunol"},{"key":"4055_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","volume":"1783","author":"GG Yegutkin","year":"2008","unstructured":"Yegutkin GG (2008) Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783:673\u2013694. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.01.024","journal-title":"Biochim Biophys Acta"},{"key":"4055_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11302-013-9357-4","volume":"9","author":"F Jacob","year":"2013","unstructured":"Jacob F, Perez Novo C, Bachert C, Van Crombruggen K (2013) Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signal 9:285\u2013306. https:\/\/doi.org\/10.1007\/s11302-013-9357-4","journal-title":"Purinergic Signal"},{"key":"4055_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","volume":"19","author":"L Antonioli","year":"2013","unstructured":"Antonioli L, Pacher P, Vizi ES, Hasko G (2013) CD39 and CD73 in immunity and inflammation. Trends Mol Med 19:355\u2013367. https:\/\/doi.org\/10.1016\/j.molmed.2013.03.005","journal-title":"Trends Mol Med"},{"key":"4055_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nri.2016.4","volume":"16","author":"C Cekic","year":"2016","unstructured":"Cekic C, Linden J (2016) Purinergic regulation of the immune system. Nat Rev Immunol 16:177\u2013192. https:\/\/doi.org\/10.1038\/nri.2016.4","journal-title":"Nat Rev Immunol"},{"key":"4055_CR32","doi-asserted-by":"publisher","unstructured":"Ravani A, Vincenzi F, Bortoluzzi A, Padovan M, Pasquini S, Gessi S, Merighi S, Borea PA, Govoni M, Varani K (2017) Role and function of A2A and A(3) adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis. Int J Mol Sci 18. https:\/\/doi.org\/10.3390\/ijms18040697","DOI":"10.3390\/ijms18040697"},{"key":"4055_CR33","first-page":"361","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria Arthritis Rheum 27:361\u2013368","journal-title":"A proposal for modification of the New York criteria Arthritis Rheum"},{"key":"4055_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1089-8","volume":"18","author":"A Bortoluzzi","year":"2016","unstructured":"Bortoluzzi A, Vincenzi F, Govoni M, Padovan M, Ravani A, Borea PA, Varani K (2016) A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Res Ther 18:192. https:\/\/doi.org\/10.1186\/s13075-016-1089-8","journal-title":"Arthritis Res Ther"},{"key":"4055_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cellimm.2009.03.020","volume":"258","author":"A Ochaion","year":"2009","unstructured":"Ochaion A, Bar-Yehuda S, Cohen S, Barer F, Patoka R, Amital H, Reitblat T, Reitblat A, Ophir J, Konfino I, Chowers Y, Ben-Horin S, Fishman P (2009) The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease. Cell Immunol 258:115\u2013122. https:\/\/doi.org\/10.1016\/j.cellimm.2009.03.020","journal-title":"Cell Immunol"},{"key":"4055_CR36","doi-asserted-by":"publisher","first-page":"R197","DOI":"10.1186\/ar3527","volume":"13","author":"K Varani","year":"2011","unstructured":"Varani K, Padovan M, Vincenzi F, Targa M, Trotta F, Govoni M, Borea PA (2011) A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release. Arthritis Res Ther 13:R197. https:\/\/doi.org\/10.1186\/ar3527","journal-title":"Arthritis Res Ther"},{"key":"4055_CR37","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1111\/bph.12227","volume":"169","author":"A Mediero","year":"2013","unstructured":"Mediero A, Perez-Aso M, Cronstein BN (2013) Activation of adenosine A(2A) receptor reduces osteoclast formation via PKA- and ERK1\/2-mediated suppression of NFkappaB nuclear translocation. Br J Pharmacol 169:1372\u20131388. https:\/\/doi.org\/10.1111\/bph.12227","journal-title":"Br J Pharmacol"},{"key":"4055_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175012","volume":"12","author":"M Matyash","year":"2017","unstructured":"Matyash M, Zabiegalov O, Wendt S, Matyash V, Kettenmann H (2017) The adenosine generating enzymes CD39\/CD73 control microglial processes ramification in the mouse brain. PLoS One 12:e0175012. https:\/\/doi.org\/10.1371\/journal.pone.0175012","journal-title":"PLoS One"},{"key":"4055_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cellimm.2011.06.010","volume":"271","author":"MJ Loza","year":"2011","unstructured":"Loza MJ, Anderson AS, O'Rourke KS, Wood J, Khan IU (2011) T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus. Cell Immunol 271:110\u2013117. https:\/\/doi.org\/10.1016\/j.cellimm.2011.06.010","journal-title":"Cell Immunol"},{"key":"4055_CR40","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1002\/eji.201344140","volume":"44","author":"J Herrath","year":"2014","unstructured":"Herrath J, Chemin K, Albrecht I, Catrina AI, Malmstrom V (2014) Surface expression of CD39 identifies an enriched Treg-cell subset in the rheumatic joint, which does not suppress IL-17A secretion. Eur J Immunol 44:2979\u20132989. https:\/\/doi.org\/10.1002\/eji.201344140","journal-title":"Eur J Immunol"},{"key":"4055_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/srep37559","volume":"6","author":"H Guo","year":"2016","unstructured":"Guo H, Zheng M, Zhang K, Yang F, Zhang X, Han Q, Chen ZN, Zhu P (2016) Functional defects in CD4+ CD25high FoxP3+ regulatory cells in ankylosing spondylitis. Sci Rep 6:37559. https:\/\/doi.org\/10.1038\/srep37559","journal-title":"Sci Rep"},{"key":"4055_CR42","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4049\/jimmunol.0803474","volume":"185","author":"H Moncrieffe","year":"2010","unstructured":"Moncrieffe H, Nistala K, Kamhieh Y, Evans J, Eddaoudi A, Eaton S, Wedderburn LR (2010) High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J Immunol 185:134\u2013143. https:\/\/doi.org\/10.4049\/jimmunol.0803474","journal-title":"J Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4055-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4055-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4055-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T14:31:55Z","timestamp":1693578715000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4055-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4055"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4055-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]},"assertion":[{"value":"18 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}